Eating Disorders and Depression: Comorbidity and Treatment
Author: Angela Bogdanova · Published: October 10, 2026 · Editorial Policy
Research cluster: Eating Disorders & Disordered Eating · Written by Artificial Sapiens
Eating disorders and depression frequently occur together, and each can complicate recognition, medical safety, treatment, and recovery from the other. Someone may experience a diagnosed eating disorder and major depressive disorder at the same time, depressive symptoms related to inadequate nutrition or severe distress, or a depressive episode that preceded the eating disorder. These situations require careful assessment because similar symptoms can have different explanations and may call for different interventions. The central clinical question is how to address eating-disorder behaviors, nutritional and physical risks, and depression within one coordinated treatment plan.
For people living with both conditions, effective care generally combines eating-disorder-specific treatment, medical and nutritional monitoring when indicated, and direct assessment and treatment of depression. The timing of individual interventions depends on urgency, the person's functioning, developmental stage, and preferences. The NICE eating-disorder guideline explicitly recommends considering treatment in parallel, as part of the same plan, or in sequence. A person does not have to demonstrate a particular body size to deserve an eating-disorder evaluation, and a depression screening score by itself does not establish a second diagnosis.
What Does Comorbidity Mean in Eating Disorders and Depression?
Comorbidity means that two clinically relevant conditions are present in the same person. In this context, it may mean anorexia nervosa, bulimia nervosa, binge-eating disorder, avoidant/restrictive food intake disorder (ARFID), or another specified feeding or eating disorder occurring alongside a depressive disorder. Clinicians distinguish a formal major depressive episode from low mood, emotional exhaustion, shame, demoralization, and mood changes associated with malnutrition. These experiences warrant care even when they do not satisfy the diagnostic criteria for major depressive disorder.
Major depressive disorder involves a sustained syndrome of depressed mood and/or loss of interest or pleasure, together with other characteristic symptoms, clinically meaningful impairment, and a diagnostic evaluation of alternative causes. Eating disorders are defined by their respective behavioral and psychological patterns, such as persistent restriction, recurrent binge eating, compensatory behaviors, or avoidant eating resulting in nutritional or psychosocial consequences. These diagnostic constructs have separate criteria and must be evaluated separately. For current clinical definitions, see the National Institute of Mental Health depression publication and the NIMH eating-disorders publication.
How common is the overlap?
Population surveys, clinical cohorts, and reviews consistently report elevated rates of depressive symptoms and depressive diagnoses among people with eating disorders. Estimates differ substantially by diagnostic group, age, recruitment setting, whether researchers measure current or lifetime depression, and whether the method is a structured clinical interview or a questionnaire. Studies of specialist clinics often include more severely affected individuals than community samples. A systematic umbrella review of psychiatric comorbidity supports the importance of this overlap but does not justify treating any single prevalence percentage as applicable to every person with an eating disorder.
A critical distinction is temporal: depression may occur before the eating disorder, begin during active eating-disorder symptoms, persist after eating behaviors improve, or recur separately. A history of depression can therefore guide clinical assessment without proving the direction of causation. Studies following people over years provide more useful information about course than a snapshot at one appointment, although they still cannot identify a single causal pathway for every patient.
Why Depression and Eating Disorders Can Be Difficult to Separate
Mood symptoms can overlap with the effects of undernutrition
Low energy, poor concentration, withdrawal, irritability, disturbed sleep, reduced motivation, and diminished pleasure may appear in depression and in people experiencing inadequate nutritional intake. Restrictive intake and rapid changes in nutritional status can affect physical stamina, cognitive flexibility, and emotional regulation. Clinicians therefore review eating history, growth and weight trajectory where relevant, medical signs, mood history before restriction, and whether symptoms change as nutrition and eating patterns improve. Nutritional rehabilitation requires clinical planning when significant malnutrition is present; it is not a substitute for evaluating persistent depression.
Improvement in nutritional status may relieve some depressive symptoms. Other people continue to have major depression, suicidal thoughts, or substantial impairment during and after medical stabilization. This is one reason to monitor mood and eating-disorder outcomes separately rather than assuming that progress in one automatically resolves the other. The 2023 American Psychiatric Association guideline calls for an integrated psychiatric and medical evaluation when treating eating disorders.
Eating-disorder distress and clinical depression are related but different
Shame following a binge episode, despair about persistent symptoms, distress around eating, and isolation caused by avoidance can produce intense suffering. These experiences may occur with or without major depressive disorder. Conversely, a person can meet criteria for major depression while continuing to work, attend school, or appear outwardly well. Assessing duration, loss of interest, hopelessness, sleep and appetite changes in context, suicidal thinking, prior episodes, and associated impairment helps clarify the clinical picture.
Appetite change has several possible meanings
Eating more or less is a potential symptom of depression, but it can also reflect an eating disorder, a medical condition, a medication effect, or ordinary variation. Recurrent loss-of-control eating with marked distress suggests a different assessment from appetite increase during a depressive episode. Fear-based avoidance, persistent sensory difficulties, deliberate restriction motivated by body-related concerns, and reduced appetite associated with gastrointestinal illness also need to be differentiated. The person's motives, consequences, and longitudinal pattern matter more than any isolated observation.
How the Depression Relationship Varies by Eating-Disorder Diagnosis
Anorexia nervosa and atypical anorexia nervosa
Anorexia nervosa may coexist with depressive symptoms and an independently diagnosable depressive disorder. Restriction, nutritional compromise, anxiety around eating, and social withdrawal can intensify mood difficulties. Atypical anorexia nervosa is classified within other specified feeding or eating disorders (OSFED); it shares important restrictive and psychological features of anorexia nervosa while a low-weight criterion is not met. Serious cardiovascular and other medical complications can occur across body sizes, particularly after rapid or substantial weight change. The Society for Adolescent Health and Medicine position paper and NICE recommendations emphasize medical risk assessment beyond a single BMI measurement.
The clinical task is to assess the depressive syndrome while treating nutritional and medical needs. In severely undernourished patients, evidence that antidepressants effectively treat independently diagnosed major depression is particularly limited. A 2026 systematic review by Besjes and colleagues found nineteen relevant studies involving 477 underweight individuals, but no randomized trial specifically tested antidepressant treatment for major depressive disorder in anorexia nervosa. This uncertainty supports specialist medication decisions and close follow-up, not a blanket assertion that depression can never require medication.
Bulimia nervosa
Bulimia nervosa involves recurrent binge-eating episodes, compensatory behaviors, and characteristic concerns about shape or weight. Depressive symptoms may appear alongside cycles of loss of control, secrecy, distress, and disrupted routines. Compensatory behaviors can cause fluid or electrolyte disturbances and other physical complications even when body weight appears unremarkable. Evidence-based treatment addresses the eating disorder directly, and clinicians also assess depression, self-harm, and potential medication risks. The NICE bulimia-treatment recommendations prioritize eating-disorder-focused psychological treatment rather than medication alone.
Binge-eating disorder
Binge-eating disorder is characterized by recurrent episodes of consuming unusually large amounts of food while experiencing loss of control and marked distress, without the regular compensatory behaviors that define bulimia nervosa. Depression may contribute to reduced activity, painful self-evaluation, and difficulties managing emotions, while eating-related distress may worsen mood. These associations do not mean that every episode is caused by emotional distress or that everyone with binge-eating disorder is depressed. Treatment should address binge eating, depression when diagnosed, and relevant medical conditions without relying on weight change as the only marker of improvement.
ARFID and other eating-disorder presentations
ARFID involves restricted or avoided food intake associated with clinically significant nutritional, growth, dependence-on-support, or psychosocial consequences, without the body-image motivation characteristic of anorexia nervosa. Fear of adverse consequences of eating, sensory sensitivity, or low interest in food can be relevant. A depressed person with reduced appetite is not automatically experiencing ARFID; likewise, low mood in someone with ARFID does not establish major depression. For OSFED, unspecified feeding or eating disorder (UFED), pica, and rumination disorder, accurate diagnosis depends on their own criteria and the person's developmental and medical context.
Orthorexia is a research and popular term for potentially impairing preoccupation with eating perceived as healthy or pure, and it is not a separate official DSM-5-TR eating-disorder diagnosis. An orthorexia questionnaire does not establish clinical depression or a specific eating disorder. The clinical assessment focuses on observable restrictions, nutritional and psychosocial consequences, related anxiety or obsessionality, and diagnostic criteria that the person may actually meet.
What Might Explain the Connection?
Shared vulnerabilities and interacting pathways
The relationship is best understood through several interacting pathways rather than one universal cause. Familial and genetic vulnerabilities, negative affect, sensitivity to stress, perfectionistic traits in some presentations, emotion-regulation difficulties, adverse experiences, social pressures, and comorbid anxiety may contribute to risk. Their roles vary by eating-disorder diagnosis and individual circumstances. Most studies identify associations; demonstrating that a factor causes both conditions requires stronger longitudinal and genetically informed designs. The NIMH eating-disorders review describes eating disorders as arising from interacting biological, psychological, and social influences.
Persistent depressed mood can make everyday eating, planning, shopping, seeking support, or engaging in treatment feel difficult. Reduced motivation or a sense of hopelessness may interfere with attendance, homework between therapy appointments, and social reconnection. On the other side, rigid eating routines, binge episodes, secrecy, exhaustion, financial burden, and conflict may reinforce low mood. When these processes maintain one another, treatment often needs to address both practical behaviors and the wider depressive syndrome.
Emotional regulation and avoidance
Some people use eating-related behaviors to reduce distress in the short term, such as avoiding feared meals or seeking temporary emotional relief. Other people develop restrictive or avoidant patterns for reasons unrelated to mood, including intense sensory responses or feared physical consequences. A functional assessment looks at what happens before and after the behavior rather than assigning the same psychological mechanism to all eating disorders. An intervention that helps one presentation may be inappropriate for another.
Malnutrition, sleep, cognition, and social isolation
Poor nutritional status, disrupted sleep, and reduced participation in valued activities can make depression harder to assess and treat. Long periods of isolation may reduce opportunities for positive experiences and social support, while depressive withdrawal can intensify isolation caused by the eating disorder. These relationships can become self-reinforcing. At the same time, improvements in mood and eating behavior may unfold at different rates; changes in appetite or energy alone are insufficient evidence of recovery from either condition.
What long-term studies can and cannot tell us
Longitudinal cohorts indicate that eating-disorder and depressive outcomes are related over time. For example, a 22-year follow-up study of women with anorexia or bulimia nervosa found an association between eating-disorder recovery and absence of major depressive disorder at follow-up. Its observational design, diagnostic composition, and participant selection limit causal conclusions and generalizability. The finding supports ongoing mood monitoring during eating-disorder recovery without proving that treating one condition necessarily cures the other.
When Depression and an Eating Disorder Become Urgent
An eating disorder with depression warrants particular attention to suicidal thoughts, self-harm, hopelessness, severe withdrawal, and inability to maintain essential self-care. Clinicians should ask directly about these concerns and assess immediate safety. People who express intent to die, have an immediate plan or access to means, or cannot remain safe need urgent in-person evaluation. In the United States, call or text 988 for a mental-health or suicide crisis; call emergency services for immediate life-threatening danger. The NIMH suicide and crisis resource explains U.S. crisis pathways.
Separate medical emergencies can arise from severe undernutrition, dehydration, electrolyte disturbance, cardiovascular instability, or complications of compensatory behaviors. Fainting, severe weakness, chest pain, palpitations, confusion, seizures, blood in vomit, or inability to drink or eat sufficiently require timely urgent assessment. Some patients need hospital monitoring or medically supervised nutritional restoration. Medical risk can occur at different body sizes, and waiting for a visibly low weight can delay life-saving care. See our medical emergency warning-signs guide and the SAHM medical management guidance.
Suicidal thoughts should never be interpreted as merely a temporary reaction to an eating disorder, and physical instability should not be dismissed as a psychological symptom of depression. A complete risk assessment reviews both conditions and any substance use, medications, other medical disorders, and available support. Even when no immediate crisis is present, worsening hopelessness or medical signs are reasons to contact the treating team promptly.
How Clinicians Assess Both Conditions
Clinical interviews and diagnostic history
A comprehensive assessment asks about eating behaviors, food avoidance, binge episodes, compensation, body-related concerns when relevant, mood and enjoyment, sleep, concentration, self-worth, suicidal thoughts, functioning, and the chronology of symptoms. Clinicians also review earlier depressive episodes, previous treatments, family and developmental history, medical conditions, and current medications. The objective is to establish which diagnostic criteria are met, what risks require immediate attention, and how each condition affects the other.
Depression can coexist with anxiety, obsessive-compulsive disorder, trauma-related symptoms, substance misuse, bipolar disorder, and other conditions. Clinicians consider whether past periods of unusually elevated or irritable mood, reduced need for sleep, or increased activity suggest a bipolar-spectrum assessment before prescribing antidepressants. For children and adolescents, growth history, family context, school functioning, and caregiver observations are often important. The AAP identification and management guidance highlights adolescent developmental and medical considerations.
Questionnaires support assessment but do not make diagnoses
Depression screening instruments such as the PHQ-9 can help identify symptoms and track change, while eating-disorder screening instruments such as SCOFF can flag possible concerns. Neither establishes the diagnosis on its own. Screens require a clinical interview and an interpretation appropriate to age and setting; depressive items involving appetite, concentration, or fatigue may be affected by nutritional compromise. The NICE guideline explicitly cautions against using eating-disorder screening tools as the sole basis for diagnosis.
Physical examination, laboratory work, and monitoring
Depending on presentation, clinicians evaluate vital signs, orthostatic symptoms, growth and weight trajectory, hydration, nutritional adequacy, and signs of medical complications. Laboratory tests and electrocardiography may be indicated, especially when there is significant restriction, compensatory behavior, rapid weight change, fainting, or medication-related cardiovascular concerns. Normal-looking weight, a normal single laboratory value, or the absence of dramatic symptoms cannot rule out meaningful risk. This physical assessment complements the psychiatric evaluation rather than functioning as a substitute.
The treatment team may monitor depressive severity and suicidal ideation alongside eating-disorder behaviors, nutrition-related goals, physical safety, social functioning, and recovery quality. Tracking the two symptom domains independently makes it easier to notice when eating behavior improves but depression persists, or when mood improves while dangerous compensatory behaviors continue. Shared information and clear responsibility for monitoring help prevent gaps in care when different clinicians are involved. These principles align with NICE recommendations on coordinated comorbidity care.
What Treatment Works When Both Are Present?
A coordinated treatment plan addresses both conditions
The foundation is individualized care by an eating-disorder-informed team that can coordinate medical, nutritional, and mental-health interventions. Treatment may involve a primary-care clinician, an eating-disorder specialist, a mental-health clinician, and a dietitian experienced in eating disorders. The team clarifies which condition poses the greatest immediate threat, identifies overlapping treatment targets, and agrees who will monitor depression, suicidality, physical status, and treatment response. Collaboration matters even when services operate in different settings.
There is no universal instruction to finish one disorder's treatment before beginning the other's. NICE recommends choosing concurrent, integrated, or sequential approaches according to severity and complexity, functioning, patient preferences, and family input when appropriate. A person with unstable vital signs needs prompt medical stabilization while mental-health risks are assessed. A person with severe major depression may need dedicated depression treatment alongside eating-disorder care. Treating both domains is an ongoing clinical process, with sequencing reviewed as the person's status changes.
Treatment for anorexia nervosa
Anorexia nervosa treatment commonly requires nutritional rehabilitation, medical oversight, and a specialist psychological intervention. For adults, NICE identifies eating-disorder-focused cognitive behavioral therapy, MANTRA, and specialist supportive clinical management as options. Adolescents may benefit from family-based approaches adapted to developmental needs and family circumstances. Psychological treatment is not reduced to weight restoration, but nutritional rehabilitation is often necessary for physical recovery and may improve capacity to engage in therapy. See the APA practice guideline and NICE anorexia recommendations.
When severe depression accompanies anorexia nervosa, a separate psychiatric assessment is essential. Clinicians may choose to initiate treatment for depression during nutritional rehabilitation or reassess specific symptoms as physical status improves, depending on urgency and history. Medication decisions require particular care because low nutritional status, cardiac instability, and coexisting medical complications may affect risks and response. Uncertainty in the antidepressant evidence is a reason for personalized specialist judgment and monitoring.
Treatment for bulimia nervosa
Eating-disorder-focused cognitive behavioral therapy is a central evidence-based treatment for bulimia nervosa in adults; guided self-help may also be used in appropriate cases according to guidelines and clinical assessment. Psychological interventions address recurrent binge eating, compensatory behaviors, associated thoughts, and factors that maintain the pattern. Clinicians may simultaneously offer evidence-based depression treatment where a depressive disorder is present. Fluoxetine is a medication with evidence and a U.S. labeled indication for bulimia nervosa in adults, but its use must be determined clinically and medication alone does not replace comprehensive eating-disorder treatment. See NICE and the official fluoxetine label.
Treatment for binge-eating disorder
For binge-eating disorder, eating-disorder-focused cognitive behavioral approaches and structured guided self-help are among the recommended interventions. Treatment focuses on reducing binge-eating episodes and distress, establishing sustainable eating patterns, and improving functioning. Depression may require separate psychotherapy and, when indicated, pharmacotherapy. Interventions should be selected according to the person's diagnoses and needs; treatment outcomes include behavior, distress, mood, and quality of life rather than a narrow emphasis on weight. NICE specifically advises against using weight loss as the goal of psychological treatment for binge-eating disorder.
Treatment for ARFID and other diagnoses
ARFID treatment is tailored to the reason for food avoidance and to nutritional, developmental, and psychosocial consequences. Specialized psychological approaches, support around nutritional adequacy, family involvement when appropriate, and coordinated medical care may be relevant. If depression co-occurs, it is evaluated and treated on its own merits. Clinical methods and medication evidence from bulimia nervosa or major depressive disorder should not simply be transferred to ARFID without evaluating the specific intervention and patient population. For OSFED, NICE advises considering the treatments used for the eating disorder the presentation most closely resembles.
Psychotherapy for depression alongside eating-disorder treatment
Cognitive behavioral therapy, behavioral activation, interpersonal psychotherapy, and other evidence-based approaches can be considered for depressive disorders depending on age, severity, prior treatment, availability, and preference. These methods address depressive symptoms and functioning; eating-disorder-specific therapy addresses eating-disorder maintenance processes. Some psychological techniques overlap, but an integrated plan still needs explicit targets and outcome monitoring for both conditions. NICE's adult depression guideline describes treatment selection and follow-up for depression, while its eating-disorder guideline governs the eating-disorder-specific care.
Therapy may begin with practical support for attendance, sleep, safety, social reconnection, and engagement, alongside a structured eating-disorder plan. When the individual feels overwhelmed, the team may simplify demands or coordinate sessions rather than allowing one service to assume that the other is managing every problem. Treatment preference, cultural context, neurodevelopmental needs, and available resources matter. A response to one therapy domain should trigger reassessment of the other, not an automatic declaration of full recovery.
Antidepressants: What the Evidence and Safety Guidance Actually Say
Medication for depression and medication for an eating disorder are distinct decisions
An antidepressant may be prescribed to treat independently diagnosed depression. Separately, a medication may have evidence or regulatory approval for an eating-disorder indication. These are different clinical decisions, with different target symptoms and evidence bases. For example, fluoxetine has a U.S. indication for bulimia nervosa in adults, whereas the evidence for treating major depression specifically in severely underweight patients with anorexia nervosa is limited. Prescribers consider diagnosis, medical status, age, other medications, preferences, prior response, and suicide risk.
The Besjes and colleagues' 2026 systematic review identified scarce and inconclusive evidence for pharmacological treatment of depression in underweight individuals, particularly those with anorexia nervosa. Its findings should be read precisely: they show an absence of direct, high-quality evidence in this population, not proof that antidepressants never help any patient. When a depressive disorder is severe, persistent, or dangerous, clinicians still need to assess and treat it appropriately while addressing the eating disorder.
Medication safety requires eating-disorder-specific assessment
Eating-disorder-related dehydration, electrolyte disturbances, bradycardia, and other medical complications can alter medication safety. NICE recommends evaluating medication risks and effectiveness in the context of malnutrition and compensatory behaviors and using electrocardiographic monitoring when prescribed agents may compromise cardiac function. Prescribers also review potential interactions, adherence barriers, and symptom changes. A medication should be started, changed, or stopped through a qualified clinician rather than as a self-directed experiment.
Bupropion is contraindicated under U.S. labeling for people with a current or prior diagnosis of anorexia nervosa or bulimia nervosa because of increased seizure risk. This is a specific prescribing safety issue, not an argument against all depression treatments in people with eating disorders. The official DailyMed bupropion label supplies the contraindication. People taking medication should consult their prescriber about individual risk and alternatives.
Why medication is not a stand-alone solution
Medication does not correct all nutritional, psychological, interpersonal, and behavioral processes that can maintain an eating disorder. An individual may experience an improvement in mood while remaining medically unstable or continuing harmful eating-disorder behaviors. NICE advises against using medication as the sole treatment for anorexia nervosa or bulimia nervosa. Comprehensive care therefore addresses medical safety, eating patterns, psychological treatment, and longer-term functioning, while tracking any medication benefits and adverse effects.
Treatment Setting: Outpatient Care, Intensive Support, and Hospitalization
Many people receive treatment in outpatient settings, often with coordinated medical and mental-health follow-up. A higher level of care may be indicated when physical instability, inability to maintain sufficient intake, severe compensatory behaviors, acute suicidality, or other serious psychiatric complications cannot be managed safely as an outpatient. Decisions depend on clinical stability and available support, not on BMI alone. The team may consider day programs, residential services where appropriate, medical hospitalization, or psychiatric hospitalization based on the principal safety needs.
If severe depression or suicide risk drives the need for inpatient psychiatric care, eating-disorder medical requirements must still be communicated and monitored. If medical complications from an eating disorder require admission, appropriate suicide-risk and depression assessment should continue. The NICE eating-disorder guidance describes coordination and care decisions; the Hub's levels-of-care guide explains how higher support is considered. Transfers between services are periods of particular vulnerability and require clear follow-up plans.
Adolescents, Adults, and Other Clinical Contexts
Children and teenagers
Adolescents may present with irritability, withdrawal, academic changes, heightened anxiety around eating, growth disruption, or medical instability that is difficult to recognize from appearance. Developmental stage, family participation, confidentiality, and school circumstances influence assessment. Family-based treatment may be appropriate for some adolescent restrictive eating disorders, while depressive symptoms or self-harm require their own evaluation. Pediatric guidance from the American Academy of Pediatrics and the Society for Adolescent Health and Medicine supports early recognition and coordinated care.
Adults, diverse body sizes, and groups often overlooked
Eating disorders and depression can affect people across gender identities, body sizes, racial and cultural groups, and stages of adulthood. Stereotypes about who has an eating disorder can delay assessment. A larger-bodied person may have severe restriction, a rapid nutritional change, or serious cardiovascular consequences; an apparently socially successful person may have profound depression. Clinicians should ask neutral, behavior-based questions and consider social stigma, access barriers, prior discrimination, and treatment preferences without presuming a diagnosis from identity or appearance.
Co-occurring medical or psychiatric conditions
Type 1 diabetes, gastrointestinal illness, chronic pain, substance use, and other psychiatric conditions can complicate both eating-related behavior and depression assessment. Medical conditions and medication effects can imitate or exacerbate depressive symptoms and change nutritional needs. Care teams may need to coordinate with relevant specialists. In pregnancy or postpartum contexts, adolescent development, and neurodivergent presentations, clinical interpretation and intervention should reflect the specific life stage and evidence base; the presence of depression does not erase the underlying eating-disorder diagnostic distinctions.
Recovery When Both Eating-Disorder and Depressive Symptoms Are Present
Recovery is multidimensional. Depending on diagnosis and stage of care, it can include improved medical stability and nutritional adequacy, reduced eating-disorder behaviors and distress, greater flexibility, meaningful social and educational participation, and improvement in depressive symptoms. Depression can persist despite changes in eating patterns, and eating-disorder symptoms can recur during later depressive episodes. Treatment teams therefore plan for both domains rather than relying on a single marker to determine whether a person is well.
Relapse-prevention discussions can identify individualized warning patterns, such as escalating food rules, recurrent loss-of-control episodes, renewed social withdrawal, disrupted sleep, increasing hopelessness, or reduced attendance at treatment. Support plans address what the person and their clinicians will do when these changes appear. Careful monitoring is especially important during transitions between treatment intensity levels, and after discharge. The Hub's recovery guide and relapse-prevention overview provide the eating-disorder-specific context.
How to Support Someone With Both Conditions
A helpful conversation names observed changes and concern without commenting on weight or appearance. For example, a family member might describe increasing isolation, distress around meals, or statements of hopelessness and ask how they can help arrange an assessment. Listening, offering practical support for appointments, and taking suicidal language seriously are more constructive than arguing about food choices or assigning motives. Supporters can also ask the clinical team how to participate appropriately and which signs require urgent help.
Where a person has both diagnoses, supporters should avoid treating every emotional change as evidence of an eating-disorder relapse or every eating difficulty as a symptom of depression. Ask what the person is experiencing, notice behavior and functioning over time, and support professional evaluation. Families of minors may be closely involved in treatment, while adults may choose how supporters participate. Carers also benefit from reliable information and from having their own support when the situation is demanding.
What the Research Has Not Yet Resolved
Research supports the clinical significance of co-occurring depression and eating disorders, but the strongest evidence often concerns treatment of individual eating-disorder diagnoses or depression separately. Trials of integrated treatment are limited, and studies differ in diagnostic methods, severity, developmental stages, and outcome definitions. Cross-sectional studies cannot establish whether depression caused the eating disorder or vice versa. Treatment protocols developed for a particular eating disorder or age group should not be presumed equally effective for other groups.
NICE explicitly identifies insufficient evidence about the most effective ways to treat eating disorders with psychiatric or physical comorbidities and calls for better controlled studies. See its research recommendation on comorbidity. The 2026 systematic review of pharmacological depression treatment in underweight patients identifies another specific research gap. These limitations make individualized, multidisciplinary assessment and separate monitoring of both outcomes important while stronger comparative evidence develops.
Frequently Asked Questions
Can eating disorders cause depression?
Eating disorders and their physical, social, and psychological consequences can contribute to depressive symptoms, and depression may also precede or intensify eating-disorder problems. Some people have both independent disorders. Research shows associations and multiple plausible pathways; a clinician examines the person's history before determining which explanations fit.
Can depression cause an eating disorder?
Depression may change appetite, energy, motivation, and emotional coping, and it may coexist with eating-disorder onset. A depressive disorder alone does not establish anorexia nervosa, bulimia nervosa, binge-eating disorder, or ARFID. Diagnosis depends on the complete eating-related pattern and its specific criteria.
Are depression and anorexia nervosa the same condition?
No. They are separate diagnoses that may occur together. Malnutrition can produce symptoms resembling depression, while major depressive disorder may be independently present. Medical evaluation and longitudinal psychiatric assessment help differentiate them.
Does treating an eating disorder automatically treat depression?
Not necessarily. Depressive symptoms sometimes improve as nutrition, eating behavior, and social functioning recover, but depression may require dedicated treatment or persist after eating-disorder symptoms lessen. Outcome monitoring should cover both domains.
Should depression or the eating disorder be treated first?
Treatment order is individualized. Immediate medical instability or suicide risk requires urgent action, while coordinated outpatient care may address both conditions in parallel. NICE advises basing the approach on severity, complexity, functioning, preferences, and family participation where appropriate.
Can someone have a serious eating disorder at a normal or higher weight?
Yes. Medical and psychiatric severity cannot be ruled out by a person's body size or one BMI value. Rapid weight changes, inadequate intake, compensatory behaviors, physical findings, and psychological impairment all matter.
Is binge eating always a sign of depression?
No. Binge-eating episodes can occur without major depression and require assessment of loss of control, recurrence, associated distress, and whether compensatory behaviors are present. Depressive symptoms should be evaluated as a separate clinical question.
Does a high PHQ-9 score diagnose depression in someone with an eating disorder?
No. The PHQ-9 is a screening and symptom-monitoring instrument, not a stand-alone diagnostic procedure. A clinician must consider duration, impairment, suicidality, medical status, nutritional effects, and differential diagnoses.
Do antidepressants work for depression in anorexia nervosa?
Evidence specifically addressing major depression in underweight patients with anorexia nervosa remains scarce and inconclusive. Clinicians may still evaluate medication for individual patients, accounting for nutritional and medical risks, depressive severity, and close monitoring.
Is fluoxetine a treatment for every eating disorder?
No. Fluoxetine has a specific U.S. labeled indication for bulimia nervosa in adults and can also be prescribed for certain depressive disorders when appropriate. Evidence and indications differ across anorexia nervosa, binge-eating disorder, ARFID, and other presentations.
When is depression with an eating disorder an emergency?
Immediate suicidal intent, inability to remain safe, or acute medical warning signs such as fainting, severe chest symptoms, confusion, or seizures call for urgent care. In the United States, 988 provides crisis support; use emergency services for life-threatening danger.
Can recovery occur even if mood symptoms return?
Yes. Recovery often involves fluctuations, and a depressive episode does not erase previously achieved progress. An updated care plan may address mood, eating-disorder symptoms, medical safety, and social functioning together to reduce the risk of further deterioration.
Related Articles
References
American Academy of Pediatrics. (2021). Identification and management of eating disorders in children and adolescents. Pediatrics. https://doi.org/10.1542/peds.2020-040279
American Psychiatric Association. (2023). Practice guideline for the treatment of patients with eating disorders, fourth edition. Official practice guideline
Besjes, M. J., Mares, S. H. W., van Elburg, A. A., & Spijker, J. (2026). The efficacy of pharmacological treatment of depression in anorexia nervosa and underweight patients: A systematic review. European Eating Disorders Review, 34(1), 55–70. https://doi.org/10.1002/erv.70008
DailyMed. (n.d.). Bupropion hydrochloride extended-release tablets: Prescribing information and contraindications. U.S. National Library of Medicine. Official drug label
DailyMed. (n.d.). Fluoxetine hydrochloride capsules: Prescribing information. U.S. National Library of Medicine. Official drug label
National Institute for Health and Care Excellence. (2017, updated). Eating disorders: Recognition and treatment (NG69). Official guideline
National Institute for Health and Care Excellence. (2017). Eating disorders in people with a comorbidity: Research recommendation NG69/4. Official research recommendation
National Institute for Health and Care Excellence. (2022, updated). Depression in adults: Treatment and management (NG222). Official guideline
National Institute of Mental Health. (n.d.). Depression. NIMH publication
National Institute of Mental Health. (n.d.). Eating disorders. NIMH publication
National Institute of Mental Health. (n.d.). Frequently asked questions about suicide. NIMH crisis resource
Society for Adolescent Health and Medicine. (2022). Medical management of restrictive eating disorders in adolescents and young adults. Journal of Adolescent Health. https://doi.org/10.1016/j.jadohealth.2022.08.006
Tan, E. J., Raut, T., Le, L. K.-D., Hay, P., Ananthapavan, J., Lee, Y. Y., & Mihalopoulos, C. (2023). The association between eating disorders and mental health: An umbrella review. Journal of Eating Disorders, 11, 51. https://doi.org/10.1186/s40337-022-00725-4